G Bjune

2.3k total citations · 1 hit paper
29 papers, 1.9k citations indexed

About

G Bjune is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, G Bjune has authored 29 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 21 papers in Microbiology and 6 papers in Infectious Diseases. Recurrent topics in G Bjune's work include Bacterial Infections and Vaccines (21 papers), Pneumonia and Respiratory Infections (18 papers) and Vibrio bacteria research studies (3 papers). G Bjune is often cited by papers focused on Bacterial Infections and Vaccines (21 papers), Pneumonia and Respiratory Infections (18 papers) and Vibrio bacteria research studies (3 papers). G Bjune collaborates with scholars based in Norway, Poland and Laos. G Bjune's co-authors include E. Arne Høiby, Einar Rosenqvist, L O Frøholm, Elisabeth Wedege, Hanne Nøkleby, Klaus Bryn, Jan Eng, Alfred Halstensen, O Closs and Øyvind Arnesen and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Infection and Immunity.

In The Last Decade

G Bjune

29 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway

1991 583 citations G Bjune, E. Arne Høiby et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Bjune Norway	19	1.6k	1.5k	240	233	137	29	1.9k
Keith Cartwright United Kingdom	26	2.0k 1.3×	2.1k 1.4×	216 0.9×	193 0.8×	166 1.2×	46	2.5k
James C. Parke United States	18	1.1k 0.7×	1.3k 0.8×	226 0.9×	188 0.8×	109 0.8×	30	1.8k
L. Pais United States	14	1.0k 0.6×	1.3k 0.8×	301 1.3×	143 0.6×	116 0.8×	15	1.7k
Viena Karanko Finland	12	1.1k 0.7×	1.4k 0.9×	244 1.0×	184 0.8×	67 0.5×	12	1.8k
Paul Balmer United Kingdom	30	1.7k 1.1×	2.0k 1.3×	387 1.6×	213 0.9×	259 1.9×	91	2.5k
Philipp Oster New Zealand	29	2.4k 1.5×	2.3k 1.5×	265 1.1×	219 0.9×	221 1.6×	57	2.7k
B. L. Brandt United States	17	919 0.6×	829 0.5×	124 0.5×	69 0.3×	90 0.7×	24	1.1k
Jamie Findlow United Kingdom	36	3.2k 2.0×	3.2k 2.0×	332 1.4×	202 0.9×	234 1.7×	93	3.6k
Jane O’Hallahan New Zealand	19	1.3k 0.8×	1.2k 0.8×	152 0.6×	128 0.5×	117 0.9×	24	1.5k
Brenda L. Brandt United States	17	594 0.4×	587 0.4×	154 0.6×	146 0.6×	64 0.5×	27	901

Countries citing papers authored by G Bjune

Since Specialization

Citations

This map shows the geographic impact of G Bjune's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bjune with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bjune more than expected).

Fields of papers citing papers by G Bjune

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Bjune. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bjune. The network helps show where G Bjune may publish in the future.

Co-authorship network of co-authors of G Bjune

This figure shows the co-authorship network connecting the top 25 collaborators of G Bjune. A scholar is included among the top collaborators of G Bjune based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Bjune. G Bjune is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nyombi, Balthazar, Knut Ivan Kristiansen, G Bjune, Fredrik Müller, & Carol Holm‐Hansen. (2008). Diversity of Human Immunodeficiency Virus Type 1 Subtypes in Kagera and Kilimanjaro Regions, Tanzania. AIDS Research and Human Retroviruses. 24(6). 761–769. 18 indexed citations

Hoang, Tran Huy, et al.. (2005). Risk factors associated with typhoid fever in Son La province, northern Vietnam. Transactions of the Royal Society of Tropical Medicine and Hygiene. 99(11). 819–826. 49 indexed citations

Jadhav, R.S., Murdo Macdonald, G Bjune, & Linda Oskam. (2001). Simplified PCR detection method for nasal Mycobacterium leprae.. PubMed. 69(4). 299–307. 22 indexed citations

Wedege, Elisabeth, E. Arne Høiby, Einar Rosenqvist, & G Bjune. (1998). Immune Responses against Major Outer Membrane Antigens of Neisseria meningitidis in Vaccinees and Controls Who Contracted Meningococcal Disease during the Norwegian Serogroup B Protection Trial. Infection and Immunity. 66(7). 3223–3231. 86 indexed citations

Andersen, Svein Rune, et al.. (1995). Short-chain lipopolysaccharide mutants of serogroup B Neisseria meningitidis of potential value for production of outer membrane vesicle vaccines. Microbial Pathogenesis. 19(3). 159–168. 19 indexed citations

Aase, Audun, et al.. (1995). Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infection and Immunity. 63(9). 3531–3536. 53 indexed citations

Brooks, Joy L., et al.. (1994). Comparison of the class-1 outer membrane protein from B:15:P1.16 Neisseria meningitidis strains isolated from patients previously immunized with a serogroup B outer membrane protein vaccine in Norway. Microbial Pathogenesis. 17(6). 425–430. 9 indexed citations

Högåsen, Kolbjørn, Terje E. Michaelsen, O. J. Mellbye, & G Bjune. (1993). Low Prevalence of Complement Deficiencies among Patients with Meningococcal Disease in Norway. Scandinavian Journal of Immunology. 37(4). 487–489. 18 indexed citations

Garred, Peter, Terje E. Michaelsen, G Bjune, Steffen Thiel, & Arne Svejgaard. (1993). A Low Serum Concentration of Mannan‐Binding Protein is Not Associated with Serogroup B or C Meningococcal Disease. Scandinavian Journal of Immunology. 37(4). 468–470. 29 indexed citations

10.

Kornstad, L., et al.. (1993). ABH secretor status, as judged by the Lewis phenotypes, in Norwegian survivors from meningococcal disease. Apmis. 101(7-12). 791–794. 2 indexed citations

11.

Aavitsland, Preben, et al.. (1991). Adverse events following vaccine or placebo injection in an efficacy trial of an outer membrane vesicle vaccine against group B meningococcal disease in Norwegian secondary schools 1988-1991.. PubMed. 14(2). 133–7. 10 indexed citations

12.

Bjune, G, E. Arne Høiby, Jon Ketil Grønnesby, et al.. (1991). Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. The Lancet. 338(8775). 1093–1096. 583 indexed citations breakdown →

13.

Rosenqvist, Einar, E. Arne Høiby, G Bjune, et al.. (1991). Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies.. PubMed. 14(2). 169–79; discussion 180. 21 indexed citations

14.

Høiby, E. Arne, G Bjune, L O Frøholm, et al.. (1991). The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.. PubMed. 14(2). 107–21; discussion 121. 14 indexed citations

15.

Høiby, E. Arne, Einar Rosenqvist, L O Frøholm, et al.. (1991). Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey.. PubMed. 14(2). 147–55; discussion 155. 86 indexed citations

16.

Rosenqvist, Einar, Elisabeth Wedege, Klaus Bryn, et al.. (1991). Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.. PubMed. 14(2). 67–79; discussion 79. 219 indexed citations

17.

Haimanot, Redda Tekle, Dominique A. Caugant, Daniel Fekadu, et al.. (1990). Characteristics of Serogroup A Neisseria meningitidis Responsible for an Epidemic in Ethiopia, 1988-89. Scandinavian Journal of Infectious Diseases. 22(2). 171–174. 22 indexed citations

18.

Bjune, G. (1987). [The new Norwegian meningococcal vaccine].. PubMed. 107(32). 2868–9. 1 indexed citations

19.

Bjune, G, T. E. Ruud, & Jan Eng. (1984). Bacterial Shock due to Transfusion with Yersinia enterocolitica Infected Blood. Scandinavian Journal of Infectious Diseases. 16(4). 411–412. 22 indexed citations

20.

Kronvall, G, et al.. (1975). Mycobacterial antigens in antibody responses of leprosy patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 43(4). 306–306. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact